PO-62 Tinzaparin: anti-cancer properties? von Dimakakos, E., Vathiotis, J., Toki, M., Charpidou, A., Pantazopoulos, K., Kotteas, E., Syrigos, K.

Volltext

Programmed Death-Ligand 1 as a Regulator of Tumor Progression and Metastasis von Vathiotis, Ioannis A., Gomatou, Georgia, Stravopodis, Dimitrios J., Syrigos, Nikolaos

Volltext

A new tool for technical standardization of the Ki67 immunohistochemical assay von Aung, Thazin Nwe, Acs, Balazs, Warrell, Jonathan, Bai, Yalai, Gaule, Patricia, Martinez-Morilla, Sandra, Vathiotis, Ioannis, Shafi, Saba, Moutafi, Myrto, Gerstein, Mark, Freiberg, Benjamin, Fulton, Regan, Rimm, David L.

Volltext

Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms von Aung, Thazin Nwe, Shafi, Saba, Wilmott, James S., Nourmohammadi, Saeed, Vathiotis, Ioannis, Gavrielatou, Niki, Fernandez, Aileen, Yaghoobi, Vesal, Sinnberg, Tobias, Amaral, Teresa, Ikenberg, Kristian, Khosrotehrani, Kiarash, Osman, Iman, Acs, Balazs, Bai, Yalai, Martinez-Morilla, Sandra, Moutafi, Myrto, Thompson, John F., Scolyer, Richard A., Rimm, David L.

Volltext

Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck von Johnson, Jennifer M, Vathiotis, Ioannis A, Harshyne, Larry A, Ali, Ayesha, Bar Ad, Voichita, Axelrod, Rita, Lorber, Emily, Curry, Joseph, Cognetti, David M, Luginbuhl, Adam J, Tuluc, Madalina, Keith, Scott, Mahoney, Mỹ G, Argiris, Athanassios

Volltext

The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis von Mulder, Frits I, Candeloro, Matteo, Kamphuisen, Pieter W, Di Nisio, Marcello, Bossuyt, Patrick M, Guman, Noori, Smit, Kirsten, Büller, Harry R, van Es, Nick

Volltext

P2.12-01 Intratumoral Conventional Type 1 Dendritic Cells (cDC1s) Predict Response to Immunotherapy in Human Non-small Cell Lung Cancer cancer (NSCLC) von Porciuncula, A., Henick, B., Gianino, N., Zugazagoitia, J., Vathiotis, I., Gavrielatou, N., Zacharek, S., Rimm, D.L., Schalper, K.A.

Volltext

Quantitative Measurement of HER2 Expression in Non–Small Cell Lung Cancer With a High-Sensitivity Assay von Liu, Matthew, Vathiotis, Ioannis, Robbins, Charles J., Chan, Nay Nwe Nyein, Moutafi, Myrto, Burela, Sneha, Xirou, Vasiliki, Schalper, Kurt A., Herbst, Roy S., Syrigos, Konstantinos, Rimm, David L.

Volltext

1336P Small cell transformation in EGFR-mutated non-small cell lung cancer (EGFR+ NSCLC): Efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with plati... von Saalfeld, F.C., Möller, J., Michels, S., Grohe, C., Wiesweg, M., Schubart, C., Alt, J., Griesinger, F., Kauffmann-Guerrero, D., Kulhavy, J., Overbeck, T.R., Pelusi, N., Rohde, G., Wesseler, C., Vathiotis, I., Veluswamy, R., Illini, O.M., Rothschild, S.I., Christopoulos, P., Wermke, M.

Volltext

Predictive capacity of immune‐related adverse events and cytokine profiling in neoadjuvant immune checkpoint inhibitor trials for head and neck squamous cell carcinoma von Alnemri, Angela E., Tekumalla, Sruti, Moroco, Annie E., Vathiotis, Ioannis, Tuluc, Madalina, Gargano, Stacey, Zhan, Tingting, Cognetti, David M., Curry, Joseph M., Argiris, Athanassios, Linnenbach, Alban, South, Andrew P., Harshyne, Larry A., Johnson, Jennifer M., Luginbuhl, Adam J.

Volltext

164P A spatially informed transcriptomic model to forecast early resistance to front-line osimertinib in advanced EGFR-mutant NSCLC von Zugazagoitia, J., Ruiz de Garibay, G., Pineda, S., Roch, B., Lopez, P. Garrido, Isla Casado, M.D., Vathiotis, I., Aguado, C., Perez, A. Callejo, Fabregat, R. Marse, Campelo, M.R. García, Cordellat, A. Blasco, Syrigos, K., Caro, R. Bernabe, Vidal, O.J. Juan, Gallego, E. Conde, Fuster, B. Hernando, Macintyre, G., Paz-Ares, L.G., Álvarez, M. Peressini

Volltext

P33.02 Comparison of PD-L1 Protein Expression Between Primary and Metastatic Lesions in Lung Cancer Patients von Moutafi, M., Tao, W., Huang, R., Haberberger, J., Alexander, B., Ramkissoon, S., Ross, J., Syrigos, K., Wei, W., Pusztai, L., Rimm, D., Vathiotis, I.

Volltext

Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemo... von Saalfeld, Felix Carl, Möller, Johanna, Christopoulos, Petros, Wenzel, Carina, Rasokat, Anna, Wang, Xuejun Alice, Vathiotis, Ioannis, König, David, Illini, Oliver, Grohé, Christian, Wiesweg, Marcel, Wesseler, Claas, Schubart, Christoph, Pelusi, Natalie, Rohde, Gernot, Overbeck, Tobias R., Kirfel, Jutta, Alt, Jürgen, Kauffmann-Guerrero, Diego, Griesinger, Frank, Kulhavy, Jonas, Allgäuer, Michael, Klimova, Anna, Schütz, Maret, Aust, Daniela E., Hochmair, Maximilian J., Rothschild, Sacha I., Syrigos, Konstantinos N., Veluswamy, Rajwanth, Michels, Sebastian, Stenzinger, Albrecht, Jöhrens, Korinna, Wermke, Martin

Volltext